> Esprit Pharma has inked a deal to collaborate with Novavax on the development of a mid-stage testosterone therapy for women with sexual dysfunction. Report
> Novartis unveiled new data that demonstrates is blockbuster blood pressure drug Diovan also influences a key marker in inflammation linked to higher risk of heart attacks and strokes. Report
> The World Health Organization wants all drug developers to register all human clinical trials so that negative results can no longer be kept secret. Report
> Shares of Arena Pharmaceuticals jumped yesterday on news that the company had started a Phase II trial of its experimental therapy for preventing hardening of the arteries. Report
> Researchers say that adding dipyridamole to aspirin may help patients ward off a second cardiovascular event better than aspirin alone. Report
> The Justice Department has joined a whistleblower lawsuit against Abbott Laboratories and Hospira, which claims they conspired to inflate Medicare and Medicaid bills. The feds claim Abbott inflated its prices to price list groups by up to 1,000 percent over what it charged providers. The tactic allegedly was used to inflate reimbursements and expand market share. Report (Wall Street Journal sub. req.)
> Synthetic Blood International has treated the fourth patient in its eight-patient study of Oxycyte for traumatic brain injury. Release
> France's Flamel Technologies has received a $1 million milestone from GSK. Release
And Finally… Spring has arrived in Alaska, and federal wildlife authorities have begun testing migratory birds for the H5N1 virus. Report